186 related articles for article (PubMed ID: 24220287)
1. Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials.
Denoeud-Ndam L; Zannou DM; Fourcade C; Taron-Brocard C; Porcher R; Atadokpede F; Komongui DG; Dossou-Gbete L; Afangnihoun A; Ndam NT; Girard PM; Cot M
J Acquir Immune Defic Syndr; 2014 Feb; 65(2):198-206. PubMed ID: 24220287
[TBL] [Abstract][Full Text] [Related]
2. Mefloquine for preventing malaria in pregnant women.
González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011444. PubMed ID: 29561063
[TBL] [Abstract][Full Text] [Related]
3. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial.
González R; Desai M; Macete E; Ouma P; Kakolwa MA; Abdulla S; Aponte JJ; Bulo H; Kabanywanyi AM; Katana A; Maculuve S; Mayor A; Nhacolo A; Otieno K; Pahlavan G; Rupérez M; Sevene E; Slutsker L; Vala A; Williamsom J; Menéndez C
PLoS Med; 2014 Sep; 11(9):e1001735. PubMed ID: 25247995
[TBL] [Abstract][Full Text] [Related]
4. Tolerability of mefloquine intermittent preventive treatment for malaria in HIV-infected pregnant women in Benin.
Denoeud-Ndam L; Clément MC; Briand V; Akakpo J; Agossou VK; Atadokpédé F; Dossou-Gbété L; Komongui DG; Afangnihoun A; Girard PM; Zannou DM; Cot M
J Acquir Immune Defic Syndr; 2012 Sep; 61(1):64-72. PubMed ID: 22706291
[TBL] [Abstract][Full Text] [Related]
5. Mefloquine for preventing malaria in pregnant women.
González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011444. PubMed ID: 30480761
[TBL] [Abstract][Full Text] [Related]
6. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial.
González R; Mombo-Ngoma G; Ouédraogo S; Kakolwa MA; Abdulla S; Accrombessi M; Aponte JJ; Akerey-Diop D; Basra A; Briand V; Capan M; Cot M; Kabanywanyi AM; Kleine C; Kremsner PG; Macete E; Mackanga JR; Massougbodgi A; Mayor A; Nhacolo A; Pahlavan G; Ramharter M; Rupérez M; Sevene E; Vala A; Zoleko-Manego R; Menéndez C
PLoS Med; 2014 Sep; 11(9):e1001733. PubMed ID: 25247709
[TBL] [Abstract][Full Text] [Related]
7. Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi.
Kapito-Tembo A; Meshnick SR; van Hensbroek MB; Phiri K; Fitzgerald M; Mwapasa V
J Infect Dis; 2011 Feb; 203(4):464-72. PubMed ID: 21216867
[TBL] [Abstract][Full Text] [Related]
8. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.
Briand V; Bottero J; Noël H; Masse V; Cordel H; Guerra J; Kossou H; Fayomi B; Ayemonna P; Fievet N; Massougbodji A; Cot M
J Infect Dis; 2009 Sep; 200(6):991-1001. PubMed ID: 19656069
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy.
Sicuri E; Fernandes S; Macete E; González R; Mombo-Ngoma G; Massougbodgi A; Abdulla S; Kuwawenaruwa A; Katana A; Desai M; Cot M; Ramharter M; Kremsner P; Slustker L; Aponte J; Hanson K; Menéndez C
PLoS One; 2015; 10(4):e0125072. PubMed ID: 25915616
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial.
González R; Nhampossa T; Mombo-Ngoma G; Mischlinger J; Esen M; Tchouatieu AM; Mendes A; Figueroa-Romero A; Zoleko-Manego R; Lell B; Lagler H; Stoeger L; Dimessa LB; El Gaaloul M; Sanz S; Méndez S; Piqueras M; Sevene E; Ramharter M; Saúte F; Menendez C;
Lancet Infect Dis; 2024 May; 24(5):476-487. PubMed ID: 38224706
[TBL] [Abstract][Full Text] [Related]
11. Cotrimoxazole versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in HIV-infected pregnant women in Bangui, Central African Republic: A pragmatic randomised controlled trial.
Manirakiza A; Tondeur L; Ketta MYB; Sepou A; Serdouma E; Gondje S; Bata GGB; Boulay A; Moyen JM; Sakanga O; Le-Fouler L; Kazanji M; Briand V; Lombart JP; Vray M
Trop Med Int Health; 2021 Oct; 26(10):1314-1323. PubMed ID: 34407273
[TBL] [Abstract][Full Text] [Related]
12. Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine.
Steketee RW; Wirima JJ; Slutsker L; Khoromana CO; Heymann DL; Breman JG
Am J Trop Med Hyg; 1996; 55(1 Suppl):50-6. PubMed ID: 8702037
[TBL] [Abstract][Full Text] [Related]
13. Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi.
Steketee RW; Wirima JJ; Slutsker L; Roberts JM; Khoromana CO; Heymann DL; Breman JG
Am J Trop Med Hyg; 1996; 55(1 Suppl):24-32. PubMed ID: 8702034
[TBL] [Abstract][Full Text] [Related]
14. Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study.
Rupérez M; González R; Mombo-Ngoma G; Kabanywanyi AM; Sevene E; Ouédraogo S; Kakolwa MA; Vala A; Accrombessi M; Briand V; Aponte JJ; Manego Zoleko R; Adegnika AA; Cot M; Kremsner PG; Massougbodji A; Abdulla S; Ramharter M; Macete E; Menéndez C
PLoS Med; 2016 Feb; 13(2):e1001964. PubMed ID: 26905278
[TBL] [Abstract][Full Text] [Related]
15. Counter-Selection of Antimalarial Resistance Polymorphisms by Intermittent Preventive Treatment in Pregnancy.
Huijben S; Macete E; Mombo-Ngoma G; Ramharter M; Kariuki S; Desai M; Shi YP; Mwangoka G; Massougbodji A; Cot M; Ndam NT; Uberegui E; Gupta H; Cisteró P; Aponte JJ; González R; Menéndez C; Mayor A
J Infect Dis; 2020 Jan; 221(2):293-303. PubMed ID: 31677349
[TBL] [Abstract][Full Text] [Related]
16. Safety of daily co-trimoxazole in pregnancy in an area of changing malaria epidemiology: a phase 3b randomized controlled clinical trial.
Manyando C; Njunju EM; Mwakazanga D; Chongwe G; Mkandawire R; Champo D; Mulenga M; De Crop M; Claeys Y; Ravinetto RM; van Overmeir C; Alessandro UD; Van Geertruyden JP
PLoS One; 2014; 9(5):e96017. PubMed ID: 24830749
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of two antifolate prophylactic strategies against malaria in HIV-positive pregnant women in Bangui, Central African Republic: study protocol for a randomized controlled trial (MACOMBA).
Manirakiza A; Sepou A; Serdouma E; Gondje S; Bata GG; Moussa S; Boulay A; Moyen JM; Sakanga O; Le-Fouler L; Kazanji M; Vray M
Trials; 2013 Aug; 14():255. PubMed ID: 23945130
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of malaria preventive treatment for HIV-infected pregnant women in sub-Saharan Africa.
Choi SE; Brandeau ML; Bendavid E
Malar J; 2017 Oct; 16(1):403. PubMed ID: 28985732
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of mefloquine and sulphadoxine-pyrimethamine for malaria prevention among pregnant women with HIV in southwest Nigeria.
Akinyotu O; Bello F; Abdus-Salam R; Arowojolu A
Int J Gynaecol Obstet; 2018 Aug; 142(2):194-200. PubMed ID: 29719927
[TBL] [Abstract][Full Text] [Related]
20. Mefloquine safety and tolerability in pregnancy: a systematic literature review.
González R; Hellgren U; Greenwood B; Menéndez C
Malar J; 2014 Feb; 13():75. PubMed ID: 24581338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
